文献速递生殖医学

卵巢刺激方案的患者负担与医疗资源利用

Patient burden and healthcare resource utilization of regimens for ovarian stimulation.
PubMed 文献 · Reprod Biomed Online · 2021-04-06

CREATE研究是一项在欧洲和亚太17个国家生殖门诊开展的前瞻性观察性研究,比较单剂量可丽芙促卵泡素α联合GnRH拮抗剂与常规每日促性腺激素方案的负担。结果显示两组情绪疲惫比例无统计学差异,但常规每日GnRH激动剂组报告经常或总是情绪疲惫的比例更高,且单剂量组门诊服务使用更少。

要点

  • 单剂量可丽芙促卵泡素α联合拮抗剂与常规方案的情绪疲惫比例无统计学差异。
  • 常规每日GnRH激动剂组报告经常或总是情绪疲惫的比例高于单剂量组。
  • 单剂量组门诊就诊、医生咨询、护士联系和经阴道超声次数均少于常规每日激动剂组。

核心结论

  • 与每日促性腺激素方案相比,可丽芙促卵泡素α治疗在心理影响上差异相似或数值很小,且门诊服务使用更低。

研究设计与样本

  • CREATE研究为前瞻性观察性研究,纳入欧洲和亚太地区17个国家生殖门诊接受IVF的女性。
  • 按治疗分为A组(单剂量可丽芙促卵泡素α联合GnRH拮抗剂)、B组(常规每日促性腺激素联合GnRH激动剂或拮抗剂)和B1i组(每日GnRH激动剂注射)。

主要发现

  • A组报告情绪疲惫的比例为11.6%,B组为13.1%,两组间无统计学差异。
  • B1i组报告经常或总是情绪疲惫的比例为16.4%,高于A组的11.6%(P = 0.026)。
  • A组心理影响问卷评分为72.7,B组为70.9,A组评分更高表明负面影响更小(P = 0.004)。
  • A组门诊就诊、医生咨询、护士联系和经阴道超声扫描次数均少于B1i组(所有P < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Do women receiving corifollitropin alfa with a gonadotrophin-releasing hormone (GnRH) antagonist experience less emotional and/or physical exhaustion than women receiving standard of care gonadotrophin with daily administration of GnRH agonist or antagonist? DESIGN: The CoRifollitropin EvAluation in PracTicE (CREATE) study was a prospective observational study of fertility clinics in 17 countries in Europe and the Asia-Pacific region. Women undergoing IVF were categorized by treatment. Group A received single-dose corifollitropin alfa plus a GnRH antagonist; group B received usual care daily gonadotrophin regimens with a GnRH agonist or antagonist; and group B1i received daily GnRH agonist injections. For the primary analysis, two items from the Controlled Ovarian Stimulation Impact questionnaire were used to assess the level of emotional and physical exhaustion associated with ovarian stimulation. Secondary end-points included the impact of ovarian stimulation-related healthcare resource use. RESULTS: No statistical difference was found between the percentage of participants reporting emotional exhaustion in group A (11.6%) and B (13.1%) or the percentage reporting being 'often' or 'always' physically exhausted. More participants in group B1i (16.4%) reported being emotionally exhausted 'often' or 'always' during ovarian stimulation compared with group A (11.6%; P = 0.026). Patient questionnaire scores for psychological impact were higher in group A compared with group B, indicating less negative impact (72.7 versus 70.9; P = 0.004). Group A had fewer clinic visits, physician consultations, nurse contacts and transvaginal ultrasound scans (all P < 0.001) than group B1. CONCLUSIONS: Treatment with corifollitropin alfa resulted in similar or numerically small differences in psychological impact and lower clinic service use compared with daily gonadotrophin regimens.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Crespi S, Hu XH, Johnson B, et al. Patient burden and healthcare resource utilization of regimens for ovarian stimulation. Reprod Biomed Online. 2021. PMID: 35151576. doi:10.1016/j.rbmo.2021.03.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。